Cohance Lifesciences Shares In Focus: Here's Why The Former Cipla Top Boss Is A Strategic Fit
Vohra's track record at Cipla makes him a strategic fit for Cohance, which is itself navigating a similar transition, from volume manufacturing toward value-based partnerships with innovator and specialty pharma clients.
from NDTV Profit - Latest https://ift.tt/AioVgq9
Vohra's track record at Cipla makes him a strategic fit for Cohance, which is itself navigating a similar transition, from volume manufacturing toward value-based partnerships with innovator and specialty pharma clients.
from NDTV Profit - Latest https://ift.tt/AioVgq9
Vohra's track record at Cipla makes him a strategic fit for Cohance, which is itself navigating a similar transition, from volume manufacturing toward value-based partnerships with innovator and specialty pharma clients.
Comments
Post a Comment